NCT05286346View on ClinicalTrials.gov

Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions
Chronic Hepatitis b
Interventions
DRUG

Tenofovir disoproxil 245mg

1 tablet q.d. for 48 weeks

DRUG

Tenofovir disoproxil fumarate 300mg

1 tablet q.d. for 48 weeks

Trial Locations (1)

Unknown

Dong-A University Hospital, Busan

All Listed Sponsors
lead

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

NCT05286346 - Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter